據報龍光集團(03380.HK)優化境內債務展期方案最多縮短九個月
《澎湃新聞》引述消息報道,龍光集團(03380.HK)對其境內債券的展期方案進行優化,在原有方案的基礎上,將AB方案展期期限由45個月縮短9個月,至36個月;C組期限由54個月縮短6個月,至48個月。
另外,展期後2023年的利息支付方案也有優化。在展期後的第一年年底利息支付50%,6個月後支付50%。對比此前的方案,集團原定是在第一年年底支付20%利息,5個月後支付30%,12個月後支付50%。
目前,龍光有14隻未償還的境內公司債和私募債,總額約203億元人民幣。
龍光股價收報0.8元,跌9.1%,成交1,879.2萬股,涉資1,560萬元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.